for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Alfresa Holdings Corporation

2784.T

Latest Trade

2,427.00JPY

Change

50.00(+2.10%)

Volume

575,200

Today's Range

2,362.00

 - 

2,430.00

52 Week Range

2,285.00

 - 

3,350.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
2,377.00
Open
2,371.00
Volume
575,200
3M AVG Volume
9.63
Today's High
2,430.00
Today's Low
2,362.00
52 Week High
3,350.00
52 Week Low
2,285.00
Shares Out (MIL)
211.67
Market Cap (MIL)
558,636.80
Forward P/E
13.72
Dividend (Yield %)
1.77

Next Event

Q2 2020 Alfresa Holdings Corp Earnings Release

Latest Developments

More

Alfresa Holdings completes share repurchase

Daiichi Sankyo announces split off and transfer of 41 long-listed products in Japan

R&I upgrades Alfresa Holdings' rating to "A+" and says stable rating outlook-R&I

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Alfresa Holdings Corporation

Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.

Industry

Biotechnology & Drugs

Contact Info

23F, Ote Center Bldg., 1-1-3, Ote-machi

+81.3.52195100

https://www.alfresa.com/

Executive Leadership

Hiroyuki Kanome

Chairman of the Board, Representative Director

Taizo Kubo

President, Representative Director

Hisashi Katsuki

Chairman & President of Subsidiaries, Director

Koichi Shimada

Chairman & President of Subsidiaries, Director

Koichi Masunaga

Vice President, President of Subsidiary, Director

Key Stats

3.00 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

2.6K

2018

2.6K

2019

2.6K

2020(E)

2.7K
EPS (JPY)

2017

142.580

2018

164.250

2019

195.791

2020(E)

173.233
Price To Earnings (TTM)
12.21
Price To Sales (TTM)
0.21
Price To Book (MRQ)
1.16
Price To Cash Flow (TTM)
10.65
Total Debt To Equity (MRQ)
0.34
LT Debt To Equity (MRQ)
0.20
Return on Investment (TTM)
8.69
Return on Equity (TTM)
3.05

Latest News

Latest News

BRIEF-tella says unit to sign agreements with Alfresa

* Says its unit plans to enter into cell products transportation consulting agreement and clinical trial products transportation management business entrust agreement with Alfresa Holdings Corp 's wholly owned unit Alfresa Corp

BRIEF-R&I affirms Alfresa Holdings rating at "A" and changes outlook to positive from stable -R&I

* Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A" -R&I

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up